APC anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
104_APC_122607
C57BL/6 mouse splenocytes stained with 104 APC
  • 104_APC_122607
    C57BL/6 mouse splenocytes stained with 104 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability
109813 25 µg $33.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109814 100 µg $116.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  2. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  5. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  6. He D, et al. 2022. Immunity. 55:159. PubMed
  7. Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed
  8. Campisi L, et al. 2022. Nature. 606:945. PubMed
  9. Cheng Y, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:964. PubMed
  10. Xu Y, et al. 2023. EMBO Rep. 24:e55503. PubMed
  11. Voss LF, et al. 2023. Front Immunol. 13:1021370. PubMed
  12. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  13. Merchak AR, et al. 2023. PLoS Biol. 21:e3002000. PubMed
  14. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  15. Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed
  16. Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
  17. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  18. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  19. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  20. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  21. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  22. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  23. Ximerakis M, et al. 2023. Nat Aging. 3:327. PubMed
  24. Buckley MT, et al. 2023. Nat Aging. 3:121. PubMed
  25. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  26. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  27. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  28. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  29. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  30. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  31. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  32. Santamaria-Martínez A, et al. 2009. Exp Cell Res. 315:3004. PubMed
  33. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  34. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  35. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  36. Brandt S, et al. 2020. J Am Soc Nephrol. 31:2589. PubMed
  37. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  38. Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
  39. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  40. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  41. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  42. Lu SX, et al. 2021. Cell. . PubMed
  43. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  44. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  45. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  46. Han CY, et al. 2020. Cell Reports. 31(13):107818. PubMed
  47. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  48. Osman A, et al. 2021. Nat Immunol. 22:1152. PubMed
  49. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  50. Marangoni F, et al. 2021. Cell. . PubMed
  51. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  52. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  53. Brocq M, et al. 2014. J Immunol. 192:6120. PubMed
  54. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  55. Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed
  56. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  57. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  58. Arsiwala T, et al. 2022. Int J Mol Sci. 23:. PubMed
  59. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  60. Jutz S, et al. 2016. J Immunol Methods. 430:10-20. PubMed
  61. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  62. Dufva O, et al. 2020. Cancer Cell. 38(3):380-399.e13. PubMed
  63. Markey K, et al. 2012. Blood. 119:5918. PubMed
  64. Woodworth JS, et al. 2017. Mucosal Immunol. 0.802083333. PubMed
  65. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  66. Xu X, et al. 2018. Cell. 175:1336. PubMed
  67. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  68. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  69. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  70. Bei T, et al. 2021. Molecules. 26:. PubMed
  71. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  72. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  73. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  74. Kalinski AL, et al. 2020. Elife. 9:00. PubMed
  75. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  76. Lim JE, et al. 2022. Front Oncol. 12:1045016. PubMed
  77. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  78. Gordon E, et al. 2015. Proc Natl Acad Sci U S A. 112: 13075 - 13080. PubMed
  79. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  80. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  81. Chen X, et al. 2020. Am J Pathol. 190:2056. PubMed
  82. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  83. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  84. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  85. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  86. Kimishima Y, et al. 2021. Nat Commun. 12:6177. PubMed
  87. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  88. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  89. Takizawa H, et al. 2011. J Exp Med. 208:273. PubMed
  90. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  91. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  92. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  93. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  94. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  95. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  96. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  97. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  98. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  99. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  100. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  101. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  102. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  103. Koide S, et al. 2022. iScience. 25:103603. PubMed
  104. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  105. Nakazawa Y, et al. 2021. Elife. 10:. PubMed
  106. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  107. Mandal RK, et al. 2020. BMC Biol. 83:18. PubMed
  108. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  109. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  110. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  111. Rivet-Noor CR, et al. 2022. Sci Rep. 12:8594. PubMed
  112. Wu B, et al. 2022. Nat Commun. 13:2155. PubMed
  113. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  114. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  115. Wang X, et al. 2022. Elife. 11:. PubMed
  116. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  117. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  118. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  119. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  120. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  121. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  122. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  123. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
RRID
AB_389210 (BioLegend Cat. No. 109813)
AB_389211 (BioLegend Cat. No. 109814)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account